Clinical Trial Update: Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the long-term immune response to Prevnar in infants, comparing previously vaccinated infants to a Prevnar-naive cohort; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Conjugate Vaccine | Phase 2 | Status: COMPLETED | Results posted: 2011-11-11